HAE Haemonetics
- 78.100
- +0.380+0.49%
- 78.100
- 0.0000.00%
Haemonetics News
Barrington Reaffirms Their Buy Rating on Haemonetics (HAE)
Haemonetics Initiated at Overweight by JP Morgan
Haemonetics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Terns Pharmaceuticals (TERN)
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $108
Haemonetics Corporation: Strategic Divestment and Innovation Drive Buy Rating With $125 Target
Haemonetics Is Maintained at Outperform by Barrington Research
Haemonetics Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Alcon (ALC)
Haemonetics Analyst Ratings
Needham Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $112
Strategic Investment and Growth Potential Drive Buy Rating for Haemonetics
Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $108 to $125
Haemonetics Is Maintained at Outperform by Barrington Research
Analysts' Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), DENTSPLY SIRONA (XRAY) and Haemonetics (HAE)
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $112 to $125
Haemonetics Analyst Ratings
Haemonetics Earns Buy Rating for Strong Q2 Performance and Margin Improvements
Haemonetics Is Maintained at Outperform by Barrington Research
No Data